Benjamin Edwards Inc’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Benjamin Edwards Inc’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$443K	Buy	+4,405	New	+$452K	﹤0.01%	1113

Other funds holding IHE

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Prospera Financial Services Dallas, Texas $7.73B AUM 29.41% 1-Year Est. Return

McElhenny Sheffield Capital Management Dallas, Texas $431M AUM 6.99% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Benjamin Edwards Inc's IHE Position: Q3 2026 in Review

Benjamin Edwards Inc opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 4,405 shares worth $443K. The stake represents ﹤0.01% of the portfolio and ranks #1113 among its holdings.

163 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

Benjamin Edwards Inc held 4,405 shares of iShares US Pharmaceuticals ETF worth $443K as of Q3 2026.
iShares US Pharmaceuticals ETF was a new Benjamin Edwards Inc position in Q3 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q3 2026, its #1113 holding.
163 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Benjamin Edwards Inc's 13F filing for Q3 2026, filed 12 Nov 2026.